Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab Across Various Solid Tumors
Published: November 17th 2021 | Updated: September 8th 2024
Part 2: Choosing a Treatment for NSCLC with MET Exon 14 Skipping Mutation
Published: August 30th 2024 | Updated: September 8th 2024
Lower-Intensity Talquetamab Dose Shows Potential in Multiple Myeloma
Published: June 21st 2024 | Updated: September 8th 2024
Durvalumab Consolidation Offers New Standard of Care for Limited-Stage SCLC
Published: September 3rd 2024 | Updated: September 8th 2024
August 2024 FDA Roundup: Key Approvals Drive Progress in Oncology
Published: August 14th 2024 | Updated: September 8th 2024
FDA Clears IND Application of Novel Paclitaxel Administration in Pancreatic Cancer